Company: DMAC
Filing Date: 2025-07-21
Form Type: 8-K
Source: 0001437749-25-023048
Chunk: 1

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-07-21
Form: 8-K
Item: Item 1.01
Chunk 1
---
 all fees and expenses incident to the Company’s performance of or compliance with the Registration Rights Agreement.

The foregoing summary description of the Securities Purchase Agreement and Registration Rights Agreement does not purport to be complete and is qualified in its entirety by the full text of the Securities Purchase Agreement and form of Registration Rights Agreement, which are attached as Exhibit 10.1 and Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference. The Securities Purchase Agreement contains representations and warranties that the parties made to, and solely for the benefit of, the other in the context of all of the terms and conditions of that agreement and in the context of the specific relationship between the parties. The provisions of the Securities Purchase Agreement, including the representations and warranties contained therein, are not for the benefit of any party other than the parties to such agreements and are not intended as documents for investors and the public to obtain factual information about the current state of affairs of the parties to those documents and agreements.